Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma

Lehrer Steven; Rheinstein Peter H.; Rosenzweig Kenneth E.

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma

【24h】

Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma

机译：改善美国癌症阶段III和IV黑色素瘤患者的存活

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2018年第10期|共1页
作者
Lehrer Steven; Rheinstein Peter H.; Rosenzweig Kenneth E.;
展开▼
作者单位

Department of Radiation OncologyIcahn School of Medicine at Mount SinaiNew York New York;

Severn Health SolutionsSeverna Park Maryland;

Department of Radiation OncologyIcahn School of Medicine at Mount SinaiNew York New York;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma [J] . Sloot Sarah, Chen Yian A., Zhao Xiuhua, Cancer: A Journal of the American Cancer Society . 2018,第10期

机译：答复改善美国联合癌症阶段III和IV黑色素瘤患者的存活
2. Melanoma-Inhibiting Activity Assay Predicts Survival in Patients Receiving a Therapeutic Cancer Vaccine After Complete Resection of American Joint Committee on Cancer Stage III Melanoma. [J] . Faries MB, Ye X, Morton DL Annals of surgical oncology . 2004,第1期

机译：黑色素瘤抑制活性测定可预测在完全切除了美国癌症三期黑色素瘤联合委员会后接受治疗性癌症疫苗的患者的存活率。
3. Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. [J] . Vereecken P, Awada A, Suciu S Melanoma research . 2009,第5期

机译：在美国癌症联合委员会III期和IV期黑色素瘤患者中评估血清galectin-3的预后意义。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
6. Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV C-reactive protein in serum is superior to lactate dehydrogenase [O] . M Deichmann, B Kahle, K Moser, 2004

机译：诊断进入美国IV期癌症联合委员会的黑色素瘤患者血清中的C反应蛋白优于乳酸脱氢酶
7. Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma [O] . Sarah Sloot, Yian A. Chen, Xiuhua Zhao, 2018

机译：答复改善美国联合癌症阶段III和IV黑色素瘤患者的存活

Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma

著录项

相似文献

相关主题

期刊订阅